Related references
Note: Only part of the references are listed.Potential anti-inflammatory effect of LQFM-021 in carrageenan-induced inflammation: The role of nitric oxide
Iziara F. Florentino et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2017)
In vitro genotoxicity and in vivo subchronic evaluation of the anti-inflammatory pyrazole compound LQFM021
Soraia Santana de Moura et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Pharmacological and toxicological evaluations of the new pyrazole compound (LQFM-021) as potential analgesic and anti-inflammatory agents
Iziara F. Florentino et al.
INFLAMMOPHARMACOLOGY (2016)
CRLI induces vascular smooth muscle relaxation and suggests a dual mechanism of eNOS activation by legume lectins via muscarinic receptors and shear stress
Bruno A. M. Rocha et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
Recent advances in bioactive pyrazoles
S. Guniz Kucukguzel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluoropheny1)-1H-pyrazol-4-y1)-2H-tetrazole (LQFM-021)
Iziara F. Florentino et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2015)
The new nitric oxide donor cyclohexane nitrate induces vasorelaxation, hypotension, and antihypertensive effects via NO/cGMP/PKG pathway
Leonidas das G. Mendes-Junior et al.
FRONTIERS IN PHYSIOLOGY (2015)
Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors
Michael P. Winters et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
New Antihypertensive Drugs Under Development
J. Tamargo et al.
CURRENT MEDICINAL CHEMISTRY (2014)
New imidazo[1,2-b]pyrazoles as anticancer agents: Synthesis, biological evaluation and structure activity relationship analysis
Sandrine Grosse et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Differential modulation of GABAA receptor function by aryl pyrazoles
Maria Paola Mascia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Synthesis and Fungicidal Activity of Novel Chloro-Containing 1-Aryl-3-oxypyrazoles with an Oximino Ester or Oximino Amide Moiety
Yuanyuan Liu et al.
MOLECULES (2014)
Vasorelaxation Induced by a New Naphthoquinone-Oxime is Mediated by NO-sGC-cGMP Pathway
Bruna P. V. Dantas et al.
MOLECULES (2014)
Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulators
Nils Griebenow et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Synthesis, Docking Studies, Pharmacological Activity and Toxicity of a Novel Pyrazole Derivative (LQFM 021)-Possible Effects on Phosphodiesterase
Daniella Ramos Martins et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2013)
Marsanidine and 7-Me-marsanidine, the new hypotensive imidazolines augment sodium and urine excretion in rats
Magdalena Wroblewska et al.
PHARMACOLOGICAL REPORTS (2013)
The new nitric oxide donor 2-nitrate-1,3-dibuthoxypropan alters autonomic function in spontaneously hypertensive rats
Maria S. Franca-Silva et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2012)
The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat
Maria S. Franca-Silva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Vasodilator efficiency of endogenous prostanoids, Ca2+-activated K+ channels and nitric oxide in rats with spontaneous, salt-dependent or NO-deficient hypertension
Michal Behuliak et al.
HYPERTENSION RESEARCH (2011)
Does enhanced respiratory-sympathetic coupling contribute to peripheral neural mechanisms of angiotensin II-salt hypertension?
Glenn M. Toney et al.
EXPERIMENTAL PHYSIOLOGY (2010)
The Gβ5-RGS7 Complex Selectively Inhibits Muscarinic M3 Receptor Signaling via the Interaction between the Third Intracellular Loop of the Receptor and the DEP Domain of RGS7
Simone L. Sandiford et al.
BIOCHEMISTRY (2009)
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
M. R. Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and NOS) potential inhibitors (III)
M. Dora Carrion et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Kidney in hypertension - Guyton redux
Thomas M. Coffman et al.
HYPERTENSION (2008)
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial
HR Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly
LMH Wing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Principal results from the international nifedipine GITS study: Intervention as a goal in hypertension treatment (INSIGHT)
MJ Brown et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2001)
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study
L Hansson et al.
LANCET (2000)
Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents
A Gursoy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
